GlassScriptPhysician profile
Andrew G King
NPI 1376584797
$4,522.37
in general payments reported to CMS, 2019-2025
14 companies · $34.70 in 2025
The $34.70 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,911 · 2020: $189 · 2021: $436 · 2022: $222 · 2023: $388 · 2024: $342 · 2025: $34.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $764.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $764.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medicrea USA, Corp. | $2,798.18 | 2019 | |
| Stryker Corporation | $323.27 | 2019-2024 | Aequalis Ascend Flex, Mesa Small Stature Spinal System |
| Globus Medical, INC. | $284.19 | 2022-2024 | Rod Link Reducer, Silc, Reflect/Reflect Hde |
| Medtronic, INC. | $183.20 | 2021-2023 | Unid_pass |
| Spine Wave, INC. | $177.43 | 2020-2021 | |
| Highridge Medical LLC | $150.00 | 2024 | The Tether |
| Depuy Synthes Sales INC. | $143.65 | 2021-2023 | Fibergraft Bg Morsels |
| Conmed Corporation | $108.45 | 2020-2025 | Visiclear |
| Sanara Medtech INC. | $94.14 | 2023 | Celleraterx |
| Wishbone Medical INC. | $70.83 | 2021 | |
| Smith+Nephew, INC. | $69.75 | 2019 | |
| Next Science LLC | $50.42 | 2020-2021 | |
| Augmedics INC. | $36.87 | 2021 | |
| Bioventus LLC | $31.99 | 2023 | Bonescalpel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.